Psoriasis management embraces many difficult tasks, with frequent challenges in case of elderly patients. The treatment of this chronic condition is particularly complicated in elderly for additional factors such as common multiple comorbidities and related polypharmacy, infection and cancer susceptibility. About 17-25% of elderly psoriatic patients suffer from a moderate-to-severe disease, requiring a systemic treatment which is often impeded due to contraindications, drug interactions and adverse events (AEs).

Apremilast efficacy and safety in elderly psoriasis patients over a 48-weeks period

Megna, M;Fabbrocini, G;Camela, E;Cinelli, E
2020

Abstract

Psoriasis management embraces many difficult tasks, with frequent challenges in case of elderly patients. The treatment of this chronic condition is particularly complicated in elderly for additional factors such as common multiple comorbidities and related polypharmacy, infection and cancer susceptibility. About 17-25% of elderly psoriatic patients suffer from a moderate-to-severe disease, requiring a systemic treatment which is often impeded due to contraindications, drug interactions and adverse events (AEs).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/802759
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 11
social impact